Uloric Heart Problems Can Begin As Soon As One Month After Treatment Begins: Study
A Chinese study finds Uloric heart problems begin very quickly after treatment with the gout drug is initiated.
Tag Archives: Heart Attack
-
-
Regular Aspirin Use Only Provides Slight Protection From Heart Disease, USPSTF Recommendations State
A task force of U.S. medical experts says regular aspirin use does more harm than good for most patients, despite its protective measures against heart disease.
-
Rinvoq Lawsuit Filed Against AbbVie By Investors Over Failure to Disclose Safety Concerns
AbbVie faces a class action lawsuit by investors who say the company mislead them about the safety of Rinvoq before new warning labels for cancer and heart problems were added.
-
Nitroglycerin Lingual Spray Recall Issued Over Defective Delivery System
A Nitroglycerin Lingual Spray warns the chest pain drug may not be dispensed properly from some pump devices, which could lead to the need for medical intervention for patients with…
-
Hypertension On The Rise In U.S. Due To Stress of Pandemic, Researchers Warn
The COVID-19 pandemic has caused an overall increase in blood pressure nationwide, putting more Americans at risk of strokes, heart attacks and other health problems, according to a new study.
-
Rinvoq Warning Label Updated to Add Cancer and Heart Risks Seen With Xeljanz Side Effects
Rinvoq will now carry label warnings on cancer and heart risks which were first discovered through a study of Xeljanz side effects.
-
Hypertension Patients Often Given Medications Which Raise Their Blood Pressure Even Higher: Study
Nearly 20% of hypertension patients are prescribed drugs which may raise their blood pressure even further, according to the findings of a new study.
-
Eli Lilly-Funded Study Claims Side Effects of Olumiant Do Not Warrant Same Adverse Label Warnings as Xeljanz
A new study announced by Eli Lilly appears to suggest Olumiant, a rheumatoid arthritis drug, does not need the same label warnings for heart problems as Xeljanz, it's competitor.
-
Xeljanz Heart Risks May Be Similar Across Other JAK Inhibitors Like Rinvoq, Oluminant: Study
A new study suggests the risk of heart problems linked to Xeljanz is similar across all other rheumatoid arthritis drugs belonging to the same class of medications.
-
Opzelura Eczema Cream Investigation Announced Over Texture Problems
The eczema cream Opzelura, made from the same active ingredient as Jakafi, is being investigated for texture issues as the entire class of drugs faces scrutiny over heart and cancer…